Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreggs Regulatory News (GRG)

Share Price Information for Greggs (GRG)

Share Price is delayed by 15 minutes
Get Live Data
1,692.00    10.00 (0.59%)
Bid:
1,692.00
Ask:
1,695.00
Spread: 3.00 (0.177%)
Market Cap: £1.73b
GRG Live PriceLast checked at - London Stock Exchange

Intraday Greggs Share Chart

Directorate Change

27 Apr 2022 07:00

RNS Number : 4419J
Greggs PLC
27 April 2022
 

 

 

 

GREGGS plc

 

Board Changes

The Board of Greggs plc announces that it has appointed Lynne Weedall as an independent non-executive director, with effect from 17 May 2022. Lynne will join the Board immediately following the close of the Annual General Meeting currently scheduled on that date.

Lynne is an experienced People and Business Transformation executive, having held senior positions most recently at Selfridges, and before that at Carphone Warehouse. Throughout her executive career Lynne has been involved in and led transformational projects in several of the companies she has worked for, which have also included Whitbread, and BUPA.

Lynne is currently the senior independent non-executive director and Remuneration Committee Chair at Dr. Martens plc, and at Stagecoach plc, and on 3 May 2022 is due to join the Board of Softcat plc as non-executive director and Chair of the Remuneration Committee. Lynne is also a non-executive director and Nominations Committee chair at Treatt plc. Lynne was previously a non-executive director and Remuneration Committee Chair of Greene King plc from 2012 until 2019 and William Hill plc from 2019 until April 2021.

The Board intends that Lynne will be appointed as Chair of the Remuneration Committee when Helena Ganczakowski steps down from the Board in 2023.

Ian Durant, Chair of Greggs, said "We are delighted that such an experienced non-executive director has accepted our invitation to join the Board. Lynne brings with her extensive experience of HR & transformational change, and will add significant value to our Board during this transitional phase and beyond".

 

Listing Rule 9.6.13R (1) to (6) Disclosure

There are no further matters required by paragraphs 9.6.13R (1) to (6) of the Listing Rules to be disclosed in relation to Lynne Weedall.

ENDS

ENQUIRIES:

 

 

Greggs plc

Hudson Sandler

Roger Whiteside, Chief Executive

Richard Hutton, Finance Director

Hattie Dreyfus / Nick Moore / Sophie Miles

Tel: 0191 281 7721

 

Tel: 020 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPURWCUPPGMQ
Date   Source Headline
27th May 202611:59 amRNSDirector/PDMR Shareholding - Amendment
19th May 20263:32 pmRNSDirector/PDMR Shareholding
13th May 20263:40 pmRNSResult of AGM
12th May 20267:00 amRNSTrading Update
30th Apr 20267:00 amRNSNotice of Trading Update
13th Apr 20267:15 amRNSAnnual Financial Report
13th Apr 20267:00 amRNS-RGreggs Publishes Sustainability Report For 2025
3rd Mar 20267:00 amRNSPreliminary Results
10th Feb 20267:00 amRNSNotice of Preliminary Results
15th Jan 20262:57 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSQ4 Trading Update
18th Dec 20257:00 amRNSNotice of Trading Update
16th Dec 20257:00 amRNSAppointment of Non-Executive Director
28th Nov 20252:45 pmRNSHolding(s) in Company
19th Nov 20254:06 pmRNSBoard Update
5th Nov 20253:29 pmRNSDirector/PDMR Shareholding
5th Nov 20253:25 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSQ3 Trading Update
15th Sep 20257:00 amRNSNotice of Trading Update
28th Aug 20257:00 amRNSBoard Update
20th Aug 202511:18 amRNSDirector/PDMR Shareholding
29th Jul 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSAppointment of Non-Executive Director
15th Jul 20257:00 amRNSNotice of Interim Results
2nd Jul 20257:00 amRNSFIRST HALF 2025 TRADING UPDATE
17th Jun 202512:29 pmRNSDirector/PDMR Shareholding
17th Jun 202512:29 pmRNSDirector/PDMR Shareholding
17th Jun 202512:27 pmRNSDirector/PDMR Shareholding
17th Jun 202511:04 amRNSDirector/PDMR Shareholding
21st May 20253:36 pmRNSResult of AGM
20th May 20257:00 amRNSTrading Update
25th Apr 20257:00 amRNSNotice of Trading Update
16th Apr 20259:43 amRNSAnnual Financial Report
16th Apr 20257:15 amRNSAnnual Financial Report
16th Apr 20257:00 amRNS-RGreggs Publishes Sustainability Report For 2024
26th Mar 20251:05 pmRNSDirector/PDMR Shareholding
26th Mar 20251:04 pmRNSDirector/PDMR Shareholding
26th Mar 202510:17 amRNSDirector/PDMR Shareholding
26th Mar 202510:14 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSPreliminary Results
6th Feb 20257:00 amRNSNotice of Preliminary Results
13th Jan 20253:15 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSQ4 Trading Update
12th Dec 20247:00 amRNSNotice of Trading Update
24th Oct 20242:04 pmRNSDirector/PDMR Shareholding
10th Oct 202410:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSQ3 Trading Update
11th Sep 20247:00 amRNSNotice of Trading Update
12th Aug 20242:15 pmRNSHolding(s) in Company
6th Aug 20244:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.